Daily Market Reports | Jan 29 2026
This story features LIFE360 INC, and other companies.
For more info SHARE ANALYSIS: 360
The company is included in ASX100, ASX200, ASX300, ALL-ORDS and ALL-TECH
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
360 AGN AUB BOT CVN GGP HGO JHX KAR MHJ NCK NWS ORG PMT PNR REA REH RWC SEK SFR SNL STO TLX VAU WC8
360 LIFE360 INC
Software & Services – Overnight Price: $28.52
Canaccord Genuity rates ((360)) as Buy (1) –
Life360’s preliminary 4Q2025 update eased concerns around user growth, triggering a sharp after-hours rally, Canaccord Genuity notes.
Monthly active users (MAU) came in around 1% above consensus, while paying circles were slightly ahead of the broker’s expectations, with preliminary 2025 ranges implying a 4.5% beat on revenue and a 12% beat on adjusted earnings (EBITDA) versus consensus.
Management indicated overall MAU growth of around 20% for 2026, above market expectations of circa 17%, suggesting the 3Q slowdown was largely transitory, according to Canaccord.
Buy is retained with an unchanged US$115 target price for Nasdaq listed stock.
This report was published on January 22, 2026.
Current Price is $28.52. Target price not assessed.
Current consensus price target is $48.56, suggesting upside of 65.7%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 EPS of 57.06 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 49.99.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 52.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 56.1.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 EPS of 66.31 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 43.01.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 82.5, implying annual growth of 58.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 35.5.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AGN ARGENICA THERAPEUTICS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.26
Petra Capital rates ((AGN)) as Buy (1) –
Argenica’s 2QFY26 quarterly update was in line, with no material surprises following completion of the Seanson phase 2 stroke trial, Moelis notes.
Cash at December end was $5.0m, modestly ahead of expectations, with the balance sheet supported by a forecast $4m R&D rebate and up to $1.2m in non-dilutive grant funding, funding the group through to the start of a Phase 2b stroke trial later in calendar 2026.
Commentary notes net operating cash outflow fell sharply to $1.4m from $4.1m in the prior quarter. Buy retained. Target price unchanged at 64c.
This report was published on January 28, 2026.
Target price is $0.64 Current Price is $0.26 Difference: $0.38
If AGN meets the Petra Capital target it will return approximately 146% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 3.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 7.43.
Forecast for FY27:
Petra Capital forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 6.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 3.94.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AUB AUB GROUP LIMITED
Insurance – Overnight Price: $30.40
Jarden rates ((AUB)) as Overweight (2) –
AUB Group’s push further offshore accelerates with the agreed acquisition of a 95.9% stake in UK broker Prestige for -$432m, materially expanding its international footprint, Jarden comments.
The deal, alongside step up agency acquisitions, is expected to be EPS neutral to mildly accretive pre synergies, while supporting margin expansion in International towards the medium term 32% target from 23.5% in FY25.
Management’s FY26 guidance excluding Prestige is re-affirmed.
The analyst lifts EPS estimates by 0.6% for FY26 and 1.6% for FY27, with the equity raising impact more than offset by incremental earnings from Prestige, step ups and cost out benefits.
Overweight rating is retained and the target price lifts to $38.20 from $37.90.
This report was published on January 28, 2026.
Target price is $38.20 Current Price is $30.40 Difference: $7.8
If AUB meets the Jarden target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $38.42, suggesting upside of 26.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 104.00 cents and EPS of 190.20 cents.
At the last closing share price the estimated dividend yield is 3.42%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.98.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 188.1, implying annual growth of 21.8%.
Current consensus DPS estimate is 102.5, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 16.1.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 116.00 cents and EPS of 212.20 cents.
At the last closing share price the estimated dividend yield is 3.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.33.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 204.3, implying annual growth of 8.6%.
Current consensus DPS estimate is 111.3, implying a prospective dividend yield of 3.7%.
Current consensus EPS estimate suggests the PER is 14.8.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BOT BOTANIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.12
Canaccord Genuity rates ((BOT)) as Buy (1) –
Botanix Pharmaceuticals’ 2Q26 result fell short of expectations, with net sales of $9.1m around -13% below Canaccord Genuity’s forecast despite 29% quarter on quarter growth
Script volumes increased 24% to 25,351, but this was still a -15% miss to the broker’s estimate, while gross to net yield improved modestly to 24%, below expectations.
Cash outflows of -$17.2m were higher than forecast, reflecting one off SG&A costs linked to the expansion of the US sales force from 27 to around 50 representatives.
Buy is retained with an unchanged target price of $0.24, although the broker flags ongoing volatility and capital overhang risks through the remainder of FY26.
This report was published on January 27, 2026.
Target price is $0.24 Current Price is $0.12 Difference: $0.12
If BOT meets the Canaccord Genuity target it will return approximately 100% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 2.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 5.71.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.00.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CVN CARNARVON ENERGY LIMITED
Crude Oil – Overnight Price: $0.10
Jarden rates ((CVN)) as Overweight (2) –
Carnarvon Energy continues to make quiet progress as it prepares for high impact exploration drilling, while awaiting greater clarity on Dorado, Jarden notes
There was little update on Dorado, a more comprehensive development pathway and timeline from operator Santos at its investor day in May is expected.
The broker highlights near term share price performance is likely to be influenced by Strike Energy’s ((STK)) news flow, given Carnarvon’s 19.9% stake.
Carnarvon remains well funded with $98m cash at December end, though interest income is expected to decline following the Strike share purchase as exploration spending ramps up.
Overweight is retained and the target price lifts to 14c from 13c, reflecting mark to market adjustments to the Strike Energy holding.
This report was published on January 23, 2026.
Target price is $0.14 Current Price is $0.10 Difference: $0.04
If CVN meets the Jarden target it will return approximately 40% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GGP GREATLAND RESOURCES LIMITED
Gold & Silver – Overnight Price: $13.89
Moelis rates ((GGP)) as Hold (3) –
At first glance, Greatland Resources’ 2Q production result confirmed a materially stronger quarter, with gold production of 86.3koz and copper output of 3.5kt well ahead of Moelis’ expectations.
Costs surprised positively, with AISC of $2,196/oz materially below forecast, while closing cash of $948m was higher despite slightly softer sales, reflecting working capital timing.
Moelis notes the recent share price rally has been supported by higher gold prices and production momentum, but valuation now leans more heavily on longer-term assumptions as capital spending ramps up.
Buy retained. Target $9.30.
This report was published on January 28, 2026.
Target price is $9.30 Current Price is $13.89 Difference: minus $4.59 (current price is over target).
If GGP meets the Moelis target it will return approximately minus 33% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $15.83, suggesting upside of 14.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 110.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 105.0, implying annual growth of 65.2%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 13.1.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 103.39 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.43.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 64.1, implying annual growth of -39.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 21.5.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HGO HILLGROVE RESOURCES LIMITED
Copper – Overnight Price: $0.06
Moelis rates ((HGO)) as Buy (1) –
Hillgrove Resources’ December quarter production came in line with expectations, though higher operating costs weighed on margins, Moelis notes
Copper production of 3.0kt met the broker’s forecast, achieved through higher throughput at lower grades, while AISC of $6.30/lb was above expectations due to elevated mining and processing costs.
The balance sheet has strengthened materially, with Moelis forecasting cash could build to around $50m by year end under consensus prices, or closer to $80m at spot.
Buy is maintained with an unchanged target price of 6.5c.
This report was published on January 27, 2026.
Target price is $0.07 Current Price is $0.06 Difference: $0.005
If HGO meets the Moelis target it will return approximately 8% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 30.00.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.57.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
JHX JAMES HARDIE INDUSTRIES PLC
Building Products & Services – Overnight Price: $33.91
Jarden rates ((JHX)) as Overweight (2) –
Jarden previews the upcoming interim result for the building materials sector with James Hardie Industries.
The analyst believes the company’s numbers have been largely de-risked due to the guidance confirmation.
EPS forecasts are lifted for FY26 and now sit 3% above consensus, and FY27-FY28 are lowered to sit 2% above consensus in both fiscal years, the broker highlights.
Overweight rating retained. Target slips to $37.17 from $39.
This report was published on January 27, 2026.
Target price is $37.17 Current Price is $33.91 Difference: $3.26
If JHX meets the Jarden target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $36.48, suggesting upside of 8.8%(ex-dividends)
The company’s fiscal year ends in March.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 168.08 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.17.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 147.4, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 22.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 191.21 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.73.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 170.2, implying annual growth of 15.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 19.7.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
KAR KAROON ENERGY LIMITED
Crude Oil – Overnight Price: $1.68
Jarden rates ((KAR)) as Overweight (2) –
Karoon Energy’s 4Q2025 update supports the view of a difficult 1H26 followed by a stronger second half, with 2026 production and cost guidance broadly in line and capex coming in well below expectations, Jarden explains.
Production of 2.37mmboe was 2% above consensus, while revenue of US$156m beat forecasts on stronger Who Dat output, offsetting weaker Brazilian volumes ahead of planned FPSO maintenance.
The first half of 2026 will be dominated by Bauna downtime and well repairs, though the return of SPS-92 and PRA-2, alongside Who Dat sidetracks, underpins a recovery into 2H26.
Lower 2026 capex guidance of -US$110m–US$135m was offered. Overweight is retained and the target price lifts to $1.75 from $1.65.
This report was published on January 27, 2026.
Target price is $1.75 Current Price is $1.68 Difference: $0.07
If KAR meets the Jarden target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $1.88, suggesting upside of 10.1%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 4.63 cents and EPS of 17.43 cents.
At the last closing share price the estimated dividend yield is 2.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.7, implying annual growth of N/A.
Current consensus DPS estimate is 5.9, implying a prospective dividend yield of 3.5%.
Current consensus EPS estimate suggests the PER is 9.1.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 4.63 cents and EPS of 17.58 cents.
At the last closing share price the estimated dividend yield is 2.75%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.56.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 15.6, implying annual growth of -16.6%.
Current consensus DPS estimate is 4.8, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 11.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
MHJ MICHAEL HILL INTERNATIONAL LIMITED
Luxury – Overnight Price: $0.44
Jarden rates ((MHJ)) as Overweight (2) –
Jarden notes Michael Hill’s 1H26 trading update points to improving momentum through the holiday period, with sales driving a clear beat to expectations and comparable EBIT guidance of $27m–$30m implying y/y growth of 12%–25%.
Group same store sales rose 3.8%, led by Canada at 6.1%, with Australia&NZ also returning to positive growth despite a smaller store footprint.
Gross margins are expected to hold around 61%, with elevated precious metal costs offset by mix and pricing, while accelerating sales appear to have come at the expense of some margin upside.
Buy. Target lifted to NZ$0.70 from NZ$0.65.
This report was published on January 27, 2026.
Current Price is $0.44. Target price not assessed.
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 1.00 cents and EPS of 2.80 cents.
At the last closing share price the estimated dividend yield is 2.27%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.71.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 4.50 cents and EPS of 7.10 cents.
At the last closing share price the estimated dividend yield is 10.23%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.20.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NCK NICK SCALI LIMITED
Furniture & Renovation – Overnight Price: $25.15
Canaccord Genuity rates ((NCK)) as Hold (3) –
Canaccord Genuity highlights Nick Scali’s early upgrade to 1H26 guidance confirms trading momentum has carried through the pre-Christmas period, with sales in Australia and New Zealand now expected to rise 10%–12% y/y,
Net profit after tax guidance for 1H26 moves to $37m–$39m, above prior guidance, reflecting stronger written sales orders and the benefit of cycling softer comparatives.
The analyst upgrades FY26 sales by 2% and lifts EBITDA by 4%, with EPS raised by 6%, leaving FY26 earnings around 4% ahead of consensus.
Hold is retained and the target price edges higher to $26.77 from $26.75
This report was published on January 23, 2026.
Target price is $26.77 Current Price is $25.15 Difference: $1.62
If NCK meets the Canaccord Genuity target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $26.04, suggesting upside of 5.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 77.80 cents and EPS of 97.00 cents.
At the last closing share price the estimated dividend yield is 3.09%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.93.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 92.1, implying annual growth of 36.4%.
Current consensus DPS estimate is 69.1, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 26.9.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 85.70 cents and EPS of 107.00 cents.
At the last closing share price the estimated dividend yield is 3.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.50.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 109.8, implying annual growth of 19.2%.
Current consensus DPS estimate is 81.9, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 22.6.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NWS NEWS CORPORATION
Print, Radio & TV – Overnight Price: $44.33
Jarden rates ((NWS)) as Overweight (2) –
News Corp’s 2Q26 result is expected to show modest earnings growth, with revenue forecast at US$2.3bn and EBITDA of US$502m, slightly ahead of consensus, Jarden notes.
Advertising remains a swing factor given macro and structural pressures, while professional information services is expected to re-accelerate following the resolution of a customer dispute in 1Q.
The analyst flags downside risk to REA Group ((REA)) listing volumes in 2H26 and softer outcomes in book publishing, partly offset by potential upside from further asset sales or AI related deals.
Jarden lifts forecasts by 2.4% for FY26 and 4.5% for FY27 on updated REA and FX assumptions, despite mixed operating conditions.
Overweight is retained. Target price is cut to $48.60 from $51.70.
This report was published on January 23, 2026.
Target price is $48.60 Current Price is $44.33 Difference: $4.27
If NWS meets the Jarden target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $57.45, suggesting upside of 32.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 30.84 cents and EPS of 156.98 cents.
At the last closing share price the estimated dividend yield is 0.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.24.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 146.1, implying annual growth of N/A.
Current consensus DPS estimate is 28.4, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 29.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 30.84 cents and EPS of 180.42 cents.
At the last closing share price the estimated dividend yield is 0.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.57.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 176.9, implying annual growth of 21.1%.
Current consensus DPS estimate is 28.4, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 24.5.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ORG ORIGIN ENERGY LIMITED
Infrastructure & Utilities – Overnight Price: $11.82
Jarden rates ((ORG)) as Neutral (3) –
Jarden expects Origin Energy to faces a busy 2026, with mixed near term news flow expected across APLNG, batteries and Kraken,.
APLNG production is tracking towards the upper end of FY26 guidance, with 1H26 output implied at around 670–675PJ, supporting expectations for a guidance upgrade, despite softer realised LNG pricing.
The Eraring life extension to April 2029 could unwind the $50m depreciation increase flagged last quarter, while early battery performance has been encouraging, commentary suggests, including a $4m arbitrage day in January.
Kraken’s US$1bn equity raising is viewed as a positive valuation data point, lifting Jarden’s Kraken valuation to US$10bn and increasing Origin’s look through value to $3.00 per share.
Neutral is retained and the target price nudges up to $11.60 from $11.55.
This report was published on January 27, 2026.
Target price is $11.60 Current Price is $11.82 Difference: minus $0.22 (current price is over target).
If ORG meets the Jarden target it will return approximately minus 2% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $11.98, suggesting upside of 0.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 60.00 cents and EPS of 69.40 cents.
At the last closing share price the estimated dividend yield is 5.08%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.03.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 63.8, implying annual growth of -26.0%.
Current consensus DPS estimate is 60.8, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 18.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 60.00 cents and EPS of 62.50 cents.
At the last closing share price the estimated dividend yield is 5.08%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 58.8, implying annual growth of -7.8%.
Current consensus DPS estimate is 60.8, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 20.2.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PMT PMET RESOURCES INC
Mining – Overnight Price: $0.73
Canaccord Genuity rates ((PMT)) as Speculative Buy (1) –
PMET Resources’ latest drilling results continue to build the case for upside beyond the CV5 deposit, with high grade lithium and caesium intersections at CV13 strengthening the development outlook, Canaccord Genuity observes.
The analyst highlights CV13 is likely to be incorporated into an updated feasibility study due in 2H26, which could improve project economics without disrupting permitting timelines.
Speculative Buy is retained and the target price is lifted to 95c from 80c.
This report was published on January 27, 2026.
Target price is $0.95 Current Price is $0.73 Difference: $0.22
If PMT meets the Canaccord Genuity target it will return approximately 30% (excluding dividends, fees and charges).
Current consensus price target is $0.78, suggesting upside of 12.0%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is -2.7, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Current consensus EPS estimate is -3.8, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
This company reports in CAD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PNR PANTORO GOLD LIMITED
Gold & Silver – Overnight Price: $5.73
Moelis rates ((PNR)) as Hold (3) –
Pantoro Gold’s 2Q26 update leaves more work required in the second half to meet FY26 guidance, although strong gold prices continue to underpin cash flow, Moelis explains.
Gold production of 22.1koz was below the broker’s forecast, with Moelis now modelling FY26 output of 97.5koz, below the lower end of guidance, while AISC of $2,571/oz exceeded expectations.
Despite softer volumes, the balance sheet strengthened further, with the cash position lifting by around $35m q/q to $189.4m, reflecting unhedged exposure to record gold prices.
Hold is retained and the target price lifts to $6.05 from $6.00.
This report was published on January 27, 2026.
Target price is $6.05 Current Price is $5.73 Difference: $0.32
If PNR meets the Moelis target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $6.05, suggesting upside of 11.0%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 51.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.13.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 73.4, implying annual growth of 395.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 7.4.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 56.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.20.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 84.9, implying annual growth of 15.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 6.4.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
REA REA GROUP LIMITED
Real Estate – Overnight Price: $190.76
Jarden rates ((REA)) as Neutral (3) –
REA Group’s 1H26 result is expected to be largely in line, with residential listing volumes known and buy yield growth already flagged at 13% in 1Q, Jarden notes.
The key risk sits in 2H26, where the analyst trims its listings outlook to -1.5% from 1.5%, citing softer momentum, noisy election year comps and potential housing market cooling.
Jarden cuts EPS forecasts by -1.9% for FY26 and -3.3% for FY27 following reduced volume and yield expectations, leaving estimated net profit modestly below consensus.
Neutral is retained and the target price is reduced to $196 from $207, reflecting lower medium term growth assumptions and heightened competitive risk from CoStar.
This report was published on January 23, 2026.
Target price is $196.00 Current Price is $190.76 Difference: $5.24
If REA meets the Jarden target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $245.96, suggesting upside of 29.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 342.30 cents and EPS of 489.00 cents.
At the last closing share price the estimated dividend yield is 1.79%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 39.01.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 500.1, implying annual growth of -2.6%.
Current consensus DPS estimate is 292.0, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 37.9.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 394.40 cents and EPS of 563.00 cents.
At the last closing share price the estimated dividend yield is 2.07%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 33.88.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 584.8, implying annual growth of 16.9%.
Current consensus DPS estimate is 339.3, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 32.4.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
REH REECE LIMITED
Furniture & Renovation – Overnight Price: $13.83
Jarden rates ((REH)) as Neutral (3) –
Reece is expected to deliver a largely in-line 1H26 result, with trading conditions remaining mixed, Jarden argues.
Margins in A&NZ remain the key focus following the reset in 2H25, with consensus assuming the prior half marked the trough, a view broadly shared by the analyst.
EPS forecasts are lowered for FY26, while later years are largely unchanged.
Neutral retained. Target slips to $11.90 from $12.30.
This report was published on January 27, 2026.
Target price is $11.90 Current Price is $13.83 Difference: minus $1.93 (current price is over target).
If REH meets the Jarden target it will return approximately minus 14% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $12.78, suggesting downside of -11.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 16.40 cents and EPS of 42.80 cents.
At the last closing share price the estimated dividend yield is 1.19%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 32.31.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 43.5, implying annual growth of -11.6%.
Current consensus DPS estimate is 16.9, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 33.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 20.20 cents and EPS of 51.40 cents.
At the last closing share price the estimated dividend yield is 1.46%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 26.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 47.8, implying annual growth of 9.9%.
Current consensus DPS estimate is 21.6, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 30.3.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
RWC RELIANCE WORLDWIDE CORP. LIMITED
Building Products & Services – Overnight Price: $3.84
Jarden rates ((RWC)) as Overweight (2) –
Jarden previews Reliance Worldwide’s 1H26 result, expecting numbers broadly in line with consensus.
The broker forecasts adjusted EBITDA of US$119.6m, 3% above consensus, and EPS 4% ahead, with the key focus on margin performance in the Americas as tariff impacts are absorbed.
Americas EBIT margin is forecast at 15.1% in 1H26, reflecting a US$30m tariff headwind weighted 75% to the first half, before recovering to 20.6% in 2H26 as pricing and cost actions flow through.
Overweight rating retained. Target price reduced to $4.47 from $4.65.
This report was published on January 27, 2026.
Target price is $4.47 Current Price is $3.84 Difference: $0.63
If RWC meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $4.53, suggesting upside of 19.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 6.79 cents and EPS of 25.44 cents.
At the last closing share price the estimated dividend yield is 1.77%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.09.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 23.2, implying annual growth of N/A.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 16.4.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 8.94 cents and EPS of 32.69 cents.
At the last closing share price the estimated dividend yield is 2.33%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 31.0, implying annual growth of 33.6%.
Current consensus DPS estimate is 8.1, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 12.3.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SEK SEEK LIMITED
Jobs & Skilled Labour Services – Overnight Price: $22.21
Jarden rates ((SEK)) as Buy (1) –
Previewing Seek’s 1H26 earnings, Jarden highlights upside risk to A&NZ yield, upgrading its FY26 estimate to 13% from 11% on stronger pricing, mix and add ons, partly offset by a softer volume outlook.
The broker forecasts 1H26 revenue of $603m, earnings (EBITDA) of $274m and adjusted NPAT of $113m, all modestly ahead of consensus, with FY26 adjusted profit expected at $209m, within guidance.
EPS estimates are lifted by 0.4% for FY26 and 1.4% for FY27, reflecting higher yield assumptions by the analyst.
The stock remains its top pick in the TMT sector in the run up to the results.
This report was published on January 22, 2026.
Target price is $29.80 Current Price is $22.21 Difference: $7.59
If SEK meets the Jarden target it will return approximately 34% (excluding dividends, fees and charges).
Current consensus price target is $30.69, suggesting upside of 41.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 55.80 cents and EPS of 58.40 cents.
At the last closing share price the estimated dividend yield is 2.51%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 38.03.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 58.2, implying annual growth of -15.3%.
Current consensus DPS estimate is 56.2, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 37.3.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 70.70 cents and EPS of 74.10 cents.
At the last closing share price the estimated dividend yield is 3.18%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.97.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 76.6, implying annual growth of 31.6%.
Current consensus DPS estimate is 68.4, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 28.3.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SFR SANDFIRE RESOURCES LIMITED
Copper – Overnight Price: $20.25
Jarden rates ((SFR)) as Underweight (4) –
Jarden notes unaudited 1H FY26 underlying earnings (EBITDA of around US$304m, marginally ahead of forecast, with the group moving to a net cash position of US$13m.
Sandfire Resources’ management reiterated a preference to build cash rather than resume dividends, given expected near-term funding commitments tied to the proposed Kalkaroo acquisition, which remains a key catalyst pending a shareholder vote in February.
While quarterly revenue and EBITDA modestly beat the analyst’s estimates, both missed consensus, with weaker production at Matsa and Motheo partly offset by stronger cost control, according to the broker.
Earnings forecasts were little changed, with FY26 EBITDA lifted by around 1%. Jarden continues to see the stock trading at a material premium to valuation.
No change to Underweight rating and Target at $14.70.
This report was published on January 22, 2026.
Target price is $14.70 Current Price is $20.25 Difference: minus $5.55 (current price is over target).
If SFR meets the Jarden target it will return approximately minus 27% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $17.60, suggesting downside of -13.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 15.42 cents and EPS of 104.09 cents.
At the last closing share price the estimated dividend yield is 0.76%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.46.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 93.6, implying annual growth of N/A.
Current consensus DPS estimate is 15.6, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 21.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 61.68 cents and EPS of 151.27 cents.
At the last closing share price the estimated dividend yield is 3.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.39.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 134.8, implying annual growth of 44.0%.
Current consensus DPS estimate is 37.4, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 15.0.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SNL SUPPLY NETWORK LIMITED
Automobiles & Components – Overnight Price: $38.56
Moelis rates ((SNL)) as Upgrade to Buy from Hold (1) –
Supply Network’s 1H26 preliminary result reinforces the view that operating leverage and capacity investment continue to drive earnings momentum, Moelis argues
Revenue of $200m rose 17% y/y and was 2% ahead of expectations, while NPAT of $22.9m beat forecasts by 3.3% and margins expanded to 11.5%, with ERP disruption proving minimal.
Strong returns are evident from recent network expansion, commentary suggests, including contributions from new WA stores and distribution centre upgrades, with further capacity investments expected to underpin future growth.
The analyst lifts EPS estimates by 1–3% across Rating is upgraded to Buy from Hold and the target price lifts to $42.90 from $40.10.
This report was published on January 26, 2026.
Target price is $42.90 Current Price is $38.56 Difference: $4.34
If SNL meets the Moelis target it will return approximately 11% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 80.40 cents and EPS of 108.30 cents.
At the last closing share price the estimated dividend yield is 2.09%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 35.60.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 97.30 cents and EPS of 128.80 cents.
At the last closing share price the estimated dividend yield is 2.52%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.94.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
STO SANTOS LIMITED
NatGas – Overnight Price: $6.82
Jarden rates ((STO)) as Underweight (4) –
Santos’s 4Q2025 production of 22.3mmboe was -4% below both Jarden and consensus, reflecting lower commissioning gas at Barossa and weaker WA oil output, despite sales revenue beating the broker’s forecast on higher PNG LNG cargoes.
Barossa has finally begun loading LNG cargoes, albeit more than two months late, while first oil at Pikka is approaching after a further US$200m capex increase driven by inflationary pressures.
Maiden 2026 guidance disappointed the analyst at the mid-point, sitting -2.3% below consensus, attributed to the conservative outlook to Barossa ramp-up uncertainty.
Commentary states investors are expected to seek clarity on how Santos will manage competing growth capex demands ahead of the May investor day.
Underweight rated with a higher target of $6 from $5.95.
This report was published on January 28, 2026.
Target price is $6.00 Current Price is $6.82 Difference: minus $0.82 (current price is over target).
If STO meets the Jarden target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.21, suggesting upside of 4.8%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 34.70 cents and EPS of 46.42 cents.
At the last closing share price the estimated dividend yield is 5.09%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.69.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 44.4, implying annual growth of N/A.
Current consensus DPS estimate is 33.7, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 15.5.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 34.08 cents and EPS of 40.40 cents.
At the last closing share price the estimated dividend yield is 5.00%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.88.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 43.4, implying annual growth of -2.3%.
Current consensus DPS estimate is 30.6, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 15.9.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TLX TELIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $11.65
Jarden rates ((TLX)) as Buy (1) –
Telix Pharmaceuticals’ fourth quarter sales of US$208m missed consensus by -3.7%, prompting Jarden to reassess its interpretation of guidance and downgrade revenue forecasts by -3.1% for 2025 and -9.8% for 2026.
Despite this, the analyst highlights encouraging signs from the Illucix and Gozellix franchise, which returned to 3.9% q/q growth following two softer quarters.
Delays to Pixclara, Zircaix and TLX-591 approvals have been pushed further into outer years, contributing to earnings downgrades and a -10.5% cut to the DCF-based target price.
A Buy rating is retained on valuation grounds, with the target reduced to $25.10 from $28.06.
This report was published on January 20, 2026.
Target price is $25.10 Current Price is $11.65 Difference: $13.45
If TLX meets the Jarden target it will return approximately 115% (excluding dividends, fees and charges).
Current consensus price target is $27.24, suggesting upside of 146.3%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 1.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 686.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -1.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.31 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 3782.47.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 7.2, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 153.6.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
VAU VAULT MINERALS LIMITED
Gold & Silver – Overnight Price: $6.18
Jarden rates ((VAU)) as Neutral (3) –
Vault Minerals’ 2Q26 disappointed, with weaker production and higher costs putting FY26 guidance at risk, particularly at Leonora, Jarden notes.
Gold production of 76.5koz missed both broker and consensus expectations, while group AISC of $3,160/oz was around 9% above Jarden’s forecast, driven by underperformance at Leonora where costs rose sharply.
FY26 guidance was retained. Leonora is viewed as the key operational risk, with first half output tracking below the midpoint of guidance and plant expansion works not due until late 2Q2026
Neutral is retained and the target price is trimmed to $3.70 from $3.75, reflecting modest EBITDA downgrades of -3% in FY26, -2% in FY27.
This report was published on January 21, 2026.
Target price is $3.70 Current Price is $6.18 Difference: minus $2.48 (current price is over target).
If VAU meets the Jarden target it will return approximately minus 40% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.05, suggesting upside of 14.6%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 52.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.79.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 51.4, implying annual growth of 126.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 12.0.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 52.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.77.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 70.1, implying annual growth of 36.4%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 8.8.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
WC8 WILDCAT RESOURCES LIMITED
New Battery Elements – Overnight Price: $0.41
Canaccord Genuity rates ((WC8)) as Speculative Buy (1) –
Canaccord Genuity sees Wildcat Resources increasingly de-risked to deliver Australia’s next lithium mine, lifting its target price to $0.75 from $0.70 and retaining a Speculative Buy.
The broker highlights Tabba Tabba as the most advanced undeveloped lithium project in Australia, with a July 2025 PFS outlining a staged open pit and underground operation producing up to 565ktpa at life of mine average AISC of US$658/t and development capex of -US$687m.
Upside is expected ahead of the DFS in 2H26, with optimisation opportunities across mine planning, capex, stripping ratios and potential petalite and tantalum by-products.
This report was published on January 27, 2026.
Target price is $0.75 Current Price is $0.41 Difference: $0.34
If WC8 meets the Canaccord Genuity target it will return approximately 83% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: 360 - LIFE360 INC
For more info SHARE ANALYSIS: AGN - ARGENICA THERAPEUTICS LIMITED
For more info SHARE ANALYSIS: AUB - AUB GROUP LIMITED
For more info SHARE ANALYSIS: BOT - BOTANIX PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: CVN - CARNARVON ENERGY LIMITED
For more info SHARE ANALYSIS: GGP - GREATLAND RESOURCES LIMITED
For more info SHARE ANALYSIS: HGO - HILLGROVE RESOURCES LIMITED
For more info SHARE ANALYSIS: JHX - JAMES HARDIE INDUSTRIES PLC
For more info SHARE ANALYSIS: KAR - KAROON ENERGY LIMITED
For more info SHARE ANALYSIS: MHJ - MICHAEL HILL INTERNATIONAL LIMITED
For more info SHARE ANALYSIS: NCK - NICK SCALI LIMITED
For more info SHARE ANALYSIS: NWS - NEWS CORPORATION
For more info SHARE ANALYSIS: ORG - ORIGIN ENERGY LIMITED
For more info SHARE ANALYSIS: PMT - PMET RESOURCES INC
For more info SHARE ANALYSIS: PNR - PANTORO GOLD LIMITED
For more info SHARE ANALYSIS: REA - REA GROUP LIMITED
For more info SHARE ANALYSIS: REH - REECE LIMITED
For more info SHARE ANALYSIS: RWC - RELIANCE WORLDWIDE CORP. LIMITED
For more info SHARE ANALYSIS: SEK - SEEK LIMITED
For more info SHARE ANALYSIS: SFR - SANDFIRE RESOURCES LIMITED
For more info SHARE ANALYSIS: SNL - SUPPLY NETWORK LIMITED
For more info SHARE ANALYSIS: STK - STRICKLAND METALS LIMITED
For more info SHARE ANALYSIS: STO - SANTOS LIMITED
For more info SHARE ANALYSIS: TLX - TELIX PHARMACEUTICALS LIMITED
For more info SHARE ANALYSIS: VAU - VAULT MINERALS LIMITED
For more info SHARE ANALYSIS: WC8 - WILDCAT RESOURCES LIMITED